Trials / Sponsors / BioNTech Research & Development, Inc.
BioNTech Research & Development, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Rad Pancreatic Carcinoma, Tumors That Express CA 19-9 | Phase 1 | 2017-06-01 |
| Terminated | Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 Pancreatic Carcinoma, Tumors That Express CA19-9 | Phase 1 | 2016-07-11 |
| Terminated | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positiv Pancreatic Cancer | Phase 1 | 2016-01-01 |